Correlation between spiral computed tomography, endoscopic ultrasonographyand findings at operation in pancreatic and ampullary tumours

Citation
Mj. Midwinter et al., Correlation between spiral computed tomography, endoscopic ultrasonographyand findings at operation in pancreatic and ampullary tumours, BR J SURG, 86(2), 1999, pp. 189-193
Citations number
20
Categorie Soggetti
Surgery,"Medical Research Diagnosis & Treatment
Journal title
BRITISH JOURNAL OF SURGERY
ISSN journal
00071323 → ACNP
Volume
86
Issue
2
Year of publication
1999
Pages
189 - 193
Database
ISI
SICI code
0007-1323(199902)86:2<189:CBSCTE>2.0.ZU;2-9
Abstract
Background: Spiral computed tomography (CT) allows high-resolution examinat ion of the pancreas, surrounding vascular structures, lymph nodes and liver . Endoscopic ultrasonography (EUS) also allows high-resolution imaging of t he pancreas and adjacent structures but is an invasive procedure. With the availability of spiral CT, the role of EUS in the investigation of patients with suspected pancreatic or ampullary tumours is unclear. Methods: Forty-eight patients with clinical suspicion of a pancreatic or am pullary tumour underwent both spiral CT and EUS. Thirty-four patients had s urgical exploration, of whom 17 underwent pancreatic resection and 17 had b iliary and gastric bypass. The results of spiral CT and EUS were compared w ith the operative findings. Results: The final histological diagnosis was ductal adenocarcinoma (24 pat ients), ampullary carcinoma (six), serous cystadenoma (two) and chronic pan creatitis (two). EUS demonstrated 33 and spiral CT 26 of the 34 primary les ions. EUS was particularly useful in the assessment of small resectable tum ours missed by spiral CT, The sensitivity and specificity of EUS and spiral CT for detecting involvement by the tumour of the superior mesenteric vein , portal vein and lymph nodes were similar, but EUS was less effective at e valuating the superior mesenteric artery. Conclusion: EUS is an important additional investigation after spiral CT in patients with a suspected pancreatic or ampullary tumour.